Balchem (BCPC) Cost of Revenue (2010 - 2026)

Balchem has reported Cost of Revenue for 17 years, with the latest figure at $180.3 million in Q2 2026.

• Cost of Revenue for Q2 2026 came in at $180.3 million, up 11.06% year-over-year; the trailing twelve-month figure through Jun 2026 was $691.8 million (up 9.29% YoY), and the FY2025 annual result was $666.5 million, up 7.94% from the prior year.
• Cost of Revenue grew to $180.3 million in Q2 2026, from $169.6 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $180.3 million in Q2 2026 and troughed at $151.1 million in Q2 2024.
• A 5-year average of $162.0 million and a median of $160.9 million in 2023 frame the typical range for Cost of Revenue.
• The widest annual swing landed in 2022, when Cost of Revenue climbed 28.41%; it then slipped 12.76% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $163.9 million in 2022, then slipped by 6.22% to $153.7 million in 2023, then slipped by 0.03% to $153.7 million in 2024, then gained by 10.45% to $169.7 million in 2025, then climbed by 6.24% to $180.3 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $180.3 million in Q2 2026, $169.6 million in Q1 2026, and $169.7 million in Q4 2025.